文献速递中医内科中药与中成药合理使用

中药改善新型冠状病毒肺炎主要症状的研究进展

Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.
PubMed 文献 · Front Pharmacol · 2020-09-11

本文综述了新型冠状病毒肺炎发热、咳嗽、乏力、腹泻等主要症状的病理生理机制,并介绍了麻黄、石膏、甘草等中药及双黄连、麻杏石甘汤等中成药在改善这些症状方面的药理作用、物质基础和临床研究,认为多数药物具有抗炎、抗氧化、抗病毒和增强免疫的活性,可能是治疗或辅助治疗COVID-19的有前景的药物。

要点

  • 发热、咳嗽、乏力是COVID-19最常见首发症状,部分患者早期以腹泻为首发表现。
  • 多种中药及中成药可显著改善上述症状,降低轻症向重症转化率及死亡率。
  • 多数药物具有抗炎、抗氧化、抗病毒及增强免疫的药理活性。

核心结论

  • 许多中药和中成药能显著改善COVID-19发热、咳嗽、乏力、腹泻等症状,治愈轻症患者,降低轻症向重症转化率及死亡率。
  • 多数药物具有抗炎、抗氧化、抗病毒和增强免疫的药理活性,可能是治疗或辅助治疗COVID-19的有前景的药物。

研究设计与样本

  • 本文为综述,总结了COVID-19主要症状的病理生理机制,并介绍了相关中药及中成药的治疗效果、物质基础、作用机制和临床研究。

主要发现

  • 发热、咳嗽和乏力是COVID-19最常见的初始症状,部分患者早期出现腹泻而非发热。
  • 麻黄、石膏、甘草、紫菀、人参、党参、苍术等中药及双黄连、麻杏石甘汤等中成药具有相应治疗效应。
  • 多数药物具有抗炎、抗氧化、抗病毒和增强免疫的药理活性。

临床怎么用

  • 可考虑使用具有抗炎、抗氧化、抗病毒和增强免疫活性的中药或中成药改善COVID-19相关症状。
  • 针对发热、咳嗽、乏力、腹泻等不同症状,可选用相应的中药或中成药进行对症治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Novel coronavirus (COVID-19) pneumonia has become a major threat to worldwide public health, having rapidly spread to more than 180 countries and infecting over 1.6 billion people. Fever, cough, and fatigue are the most common initial symptoms of COVID-19, while some patients experience diarrhea rather than fever in the early stage. Many herbal medicine and Chinese patent medicine can significantly improve these symptoms, cure the patients experiencing a mild 22form of the illness, reduce the rate of transition from mild to severe disease, and reduce mortality. Therefore, this paper summarizes the physiopathological mechanisms of fever, cough, fatigue and diarrhea, and introduces Chinese herbal medicines (Ephedrae Herba, Gypsum Fibrosum, Glycyrrhizae Radix et Rhizoma, Asteris Radix et Rhizoma, Ginseng Radix et Rhizoma, Codonopsis Radix, Atractylodis Rhizoma, etc.) and Chinese patent medicines (Shuang-huang-lian, Ma-xing-gan-shi-tang, etc.) with their corresponding therapeutic effects. Emphasis was placed on their material basis, mechanism of action, and clinical research. Most of these medicines possess the pharmacological activities of anti-inflammatory, antioxidant, antiviral, and immunity-enhancement, and may be promising medicines for the treatment or adjuvant treatment of COVID-19 patients.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Luo CH, Ma LL, Liu HM, et al. Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine. Front Pharmacol. 2020. PMID: 33013395. doi:10.3389/fphar.2020.556885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。